LY2109761
LY2109761
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name LY2109761
CAS700874-71-1
FormulaC26H27N5O2
MW441.52
AppearanceWhite to yellow powder
Storage conditionStore in a dry and dark sealed container, short-term (weeks to months) storage at 0-4 ℃, long-term (months to years) storage at -20 ℃.
Security information
Product details

LY2109761 is a novel selective TGF-β receptor type I/II (TβRI/II) dual inhibitor with Ki of 38 nM and 300 nM in a cell-free assay, respectively; shown to negatively affect the phosphorylation of Smad2. LY2109761 blocks autophagy and induces apoptosis.


Related literature
Related
Sorry, no related items
History
Tesevatinib (Synonyms: XL-647; EXEL-7647; KD-019)
3-(1-(((3r,5r,7r)-adamantan-1-yl)methyl)-5-methyl-1H-pyrazol-4-yl)-6-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)picolinic acid
LY2109761
Cycloastragenol | Cyclosiversigenin | Astramembrangenin | Cyclosieversigenin
TT16Ainh-A01
MK-2206 dihydrochloride | MK-2206 ·2HCl
Lanifibranor (IVA337)
Ocaratuzumab (Anti-CD20)
Donanemab
Phenformin Hydrochloride | Phenformin HCl